GATA2缺陷综合征的谱系
综述GATA2缺陷综合征的临床谱系:遗传性或新发GATA2杂合突变导致非结核分枝杆菌、细菌、真菌及人乳头瘤病毒感染、淋巴水肿、肺泡蛋白沉积症和骨髓增生异常。临床表现源于多能祖细胞丢失致B淋巴细胞、单核细胞、自然杀伤细胞及树突状细胞减少。异基因造血干细胞移植可逆转表型,但无症状携带者、髓系进展机制、遗传早现及抢先移植作用等问题待解。
要点
- GATA2缺陷综合征由遗传性或新发GATA2杂合突变引起,临床表型高度可变。
- 临床特征包括分枝杆菌、细菌、真菌及人乳头瘤病毒感染、淋巴水肿、肺泡蛋白沉积症和骨髓增生异常。
- 骨髓衰竭常表现为骨髓细胞减少,可进展为髓系恶性肿瘤,异基因造血干细胞移植可逆转表型。
核心结论
- GATA2缺陷综合征由GATA2杂合突变引起,临床谱系广泛,异基因造血干细胞移植可逆转表型。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- GATA2缺陷综合征临床特征包括非结核分枝杆菌、细菌、真菌及人乳头瘤病毒感染、淋巴水肿、肺泡蛋白沉积症和骨髓增生异常,即使同一家族中携带相同GATA2突变者,发病年龄及是否发病也高度可变。
- 临床表现源于多能祖细胞丢失,导致B淋巴细胞、单核细胞、自然杀伤细胞及树突状细胞减少,引起相应血细胞减少和后续感染。
- 骨髓衰竭通常表现为骨髓细胞减少,病态造血可缺如或轻微,但通常演变为多系病态造血伴显著巨核细胞病态造血,部分病例进展为髓系恶性肿瘤,即骨髓增生异常综合征、急性髓系白血病和慢性粒单核细胞白血病。
- 上述3种恶性肿瘤常伴单体7、三体8及ASXL1或STAG2获得性突变,且髓系恶性肿瘤可能为首发表现而未识别其他综合征特征。
- 异基因造血干细胞移植可逆转GATA2缺陷综合征表型。
关键数值与推荐
- GATA2缺陷综合征的临床特征包括非结核分枝杆菌、细菌、真菌及人乳头瘤病毒感染、淋巴水肿、肺泡蛋白沉积症和骨髓增生异常。
- 骨髓衰竭通常以骨髓细胞减少为特征,病态造血可缺如或轻微,但通常演变为多系病态造血伴显著巨核细胞病态造血。
- 髓系恶性肿瘤包括骨髓增生异常综合征、急性髓系白血病和慢性粒单核细胞白血病,常伴单体7、三体8及ASXL1或STAG2获得性突变。
- 异基因造血干细胞移植可逆转GATA2缺陷综合征表型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出GATA2缺陷综合征仍存在重要未解问题:为何部分家族成员携带GATA2有害突变仍无症状、导致髓系进展的遗传学改变是什么、明显遗传早现的原因是什么、抢先异基因造血干细胞移植的作用是什么。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inherited or de novo germ line heterozygous mutations in the gene encoding the transcription factor GATA2 lead to its deficiency. This results in a constellation of clinical features including nontuberculous mycobacterial, bacterial, fungal, and human papillomavirus infections, lymphedema, pulmonary alveolar proteinosis, and myelodysplasia. The onset, or even the presence, of disease is highly variable, even in kindreds with the identical mutation in GATA2. The clinical manifestations result from the loss of a multilineage progenitor that gives rise to B lymphocytes, monocytes, natural killer cells, and dendritic cells, leading to cytopenias of these lineages and subsequent infections. The bone marrow failure is typically characterized by hypocellularity. Dysplasia may either be absent or subtle but typically evolves into multilineage dysplasia with prominent dysmegakaryopoiesis, followed in some instances by progression to myeloid malignancies, specifically myelodysplastic syndrome, acute myelogenous leukemia, and chronic myelomonocytic leukemia. The latter 3 malignancies often occur in the setting of monosomy 7, trisomy 8, and acquired mutations in ASXL1 or in STAG2. Importantly, myeloid malignancy may represent the primary presentation of disease without recognition of other syndromic features. Allogeneic hematopoietic stem cell transplantation (HSCT) results in reversal of the phenotype. There remain important unanswered questions in GATA2 deficiency, including the following: (1) Why do some family members remain asymptomatic despite harboring deleterious mutations in GATA2? (2) What are the genetic changes that lead to myeloid progression? (3) What causes the apparent genetic anticipation? (4) What is the role of preemptive HSCT?
引用
- Calvo KR, Hickstein DD. The spectrum of GATA2 deficiency syndrome. Blood. 2023. PMID: 36455197. doi:10.1182/blood.2022017764
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。